-
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer
Study
EGAS50000000793
-
Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer
Study
EGAS50000000831
-
Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
Study
EGAS50000000809
-
Raw sequencing files from WGS and RNA-Seq
Study
EGAS50000000186
-
Spatial heterogeneity, stromal phenotypes, and therapeutic vulnerabilities in colorectal cancer peritoneal metastasis
Study
EGAS50000000813
-
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals
Study
EGAS50000000715
-
Single-cell Transcriptome Profiling of Treatment-naïve and Post-treatment Colorectal Cancer: Insights into Putative Mechanisms of Chemoresistance
Study
EGAS50000000830
-
Tumor-resident T-cell regulate responses to checkpoint blockade immunotherapies
Study
EGAS50000000826
-
WES in muscle-invasive bladder cancer (MIBC) treated with durvalumab plus olaparib in the neoadjuvant setting: NEODURVARIB trial
Study
EGAS50000000791
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Accurate mutation detection in leukemia by re-sequencing a cancer gene set
Study
EGAS00001000268
-
Inferring tumor genomes from peripheral blood i.e. CTCs and plasma-DNA using deep sequencing and targeted enrichment
Study
EGAS00001000337
-
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single nucleotide variants and tumoral heterogeneity by massively parallel sequencing
Study
EGAS00001000370
-
The genomic landscape of large and small tumors in early-onset prostate cancer patients
Study
EGAS00001000383
-
A Cancer Cell-Line Titration Series for Evaluating Somatic Classification
Study
EGAS00001001016
-
ICGC PanCancer Analysis of Whole Genomes
Study
EGAS00001001692
-
Single cell sequencing of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Study
EGAS00001002845
-
AUBTRG - Whole Exome Sequencing of Diffuse Glioma Samples
Study
EGAS00001003035
-
Transcriptome Sequencing Data of High Grade Serous Ovarian Cancer
Study
EGAS00001004714
-
BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression
Study
EGAS00001004800
-
Integrated Genomic and Transcriptomic Analysis Reveals Unique Characteristics of Hepatic Metastases and Pro-metastatic Role of Complement C1q in Pancreatic Ductal Adenocarcinoma
Study
EGAS00001004821
-
DEREGULATION OF PRE-mRNA SPLICING IN MISMATCH REPAIR DEFICIENT COLORECTAL CANCER
Study
EGAS00001004863
-
EAC Genomic data
Study
EGAS00001004887
-
The WID-EC test for the detection and risk prediction of endometrial cancer
Study
EGAS00001005033
-
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
Study
EGAS00001004975
-
The DNA methylome of cervical cells and risk of ovarian cancer
Study
EGAS00001005045
-
Molecular analysis of inflammatory myofibroblastic tumor (WGS and WES)
Study
EGAS00001005081
-
IG-MYC rearrangement defines a high-risk subgroup of B-cell precursor acute lymphoblastic leukaemia
Study
EGAS00001005111
-
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis
Study
EGAS00001005115
-
Identification of novel colorectal cancer predisposition genes
Study
EGAS00001005118
-
An integrated multi-omic cellular atlas of human breast cancers
Study
EGAS00001005173
-
Secondary Resistance to Anti-EGFR Therapy by Transcriptional Reprogramming in Patient-Derived Colorectal Cancer Models (hipo_B012)
Study
EGAS00001005320
-
Evolutionary trajectories and clonal migration underlying tumor progression and lymph node metastasis in resectable lung cancer
Study
EGAS00001005242
-
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Study
EGAS00001005791
-
Identification of early disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis (hipo_K34R)
Study
EGAS00001005327
-
Genomic Analysis of Focal Nodular Hyperplasia with Associated Hepatocellular Carcinoma Unveils its Malignant Potential
Study
EGAS00001005313
-
Novel de novo pathogenic variant in the GNAI1 as a cause of severe disorders of intellectual development with autistic features
Study
EGAS00001005355
-
Evaluating CRISPR-based Prime Editing for cancer modeling and CFTR repair in organoids
Study
EGAS00001005358
-
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Study
EGAS00001005472
-
A renal cell carcinoma tumorgraft platform to advance precision medicine
Study
EGAS00001005516
-
Pearl study
Study
EGAS00001005523
-
Minor intron splicing efficiency increases with the development of lethal prostate cancer
Study
EGAS00001005546
-
Mutation and Microsatellite Burden Predict Response to PD-1 Inhibition in Children with Germline DNA Replication Repair Deficiency: An Observational Registry Study
Study
EGAS00001005579
-
Berlin Neuroblastoma Dataset Update 2021
Study
EGAS00001005604
-
Genomic Signatures Define Three Subtypes of EGFR-Mutant Stage II-III NSCLC With Distinct Adjuvant Therapy Outcomes
Study
EGAS00001005632
-
DNA methylation and Panel sequencing for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs)
Study
EGAS00001005731
-
IN UTERO ORIGIN OF MYELOFIBROSIS PRESENTING IN ADULT MONOZYGOTIC TWINS AFTER A PROLONGED DISEASE LATENCY
Study
EGAS00001005744
-
Paired healthy & tumor organoid Biobank _B15PON
Study
EGAS00001005865
-
Initial cohort of 500 solid tumors screened for Basket of Baskets
Study
EGAS00001005893
-
Molecular analysis in bowel malignancies in cancer survivors vs. primary malignancies
Study
EGAS00001005940
-
Patient-derived organoids_Vumc
Study
EGAS00001005947
-
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids induces a carcinoma-like genotype
Study
EGAS00001005949
-
Oesophageal adenocarcinoma whole exome and RNA-seq raw sequencing data
Study
EGAS00001005957
-
Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma
Study
EGAS00001006027
-
Tumour evolvability metrics predict recurrence in advanced localised prostate cancer (normal data)
Study
EGAS00001006098
-
Anti-Cancer Therapies Induce Mutations in Adult Stem Cells in a Tissue-Specific Manner
Study
EGAS00001006042
-
Genomic profiling of metastatic basal cell carcinoma reveals candidate drivers of disease and therapeutic targets
Study
EGAS00001006148
-
Enhancer profiling to identify identifies epigenetic markers of endocrine resistance in metastatic castration resistant prostate cancer patients
Study
EGAS00001006161
-
Serum Proteome Profiling Identifies Early Markers of Therapeutic Response to Neoadjuvant Chemotherapy of Breast Cancer
Study
EGAS00001006228
-
Biomarker Data from KATHERINE: A Phase III Study of Adjuvant Trastuzumab Emtansine versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer
Study
EGAS00001006229
-
Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR
Study
EGAS00001006247
-
Molecular characterization of a renal cell carcinoma PDX cohort
Study
EGAS00001006249
-
Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicine (Hipo_021)
Study
EGAS00001006317
-
ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
Study
EGAS00001006268
-
Characterization of alternative promoter usage in advanced prostate cancer
Study
EGAS00001006275
-
Evolutionary histories of breast cancer and related clones
Study
EGAS00001006282
-
Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Study
EGAS00001006342
-
Soft tissue sarcoma sequencing data
Study
EGAS00001006356
-
RNAseq analysis on metastatic Colorectal Cancer xenografts samples
Study
EGAS00001006492
-
Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.
Study
EGAS00001006364
-
Induction Failure in Childhood and Young Adult T-cell Acute Lymphoblastic Leukemia
Study
EGAS00001006411
-
WGS of PMBCL
Study
EGAS00001006452
-
Complex patterns of genomic heterogeneity identified in 42 tumor samples and ctDNA of a pulmonary atypical carcinoid patient
Study
EGAS00001006530
-
Sequencing Data of HGSC patient-derived cell lines and organoids
Study
EGAS00001006557
-
Follicular Lymphoma Whole Genome and Transcriptome Sequencing
Study
EGAS00001006646
-
bulk RNA-Seq of colorectal cancer patient samples
Study
EGAS00001006666
-
Genomic profiling of subcutaneous patient derived xenograft models of solid childhood cancer
Study
EGAS00001006710
-
Human primary and metastatic colorectal cancer (CRC) samples
Study
EGAS00001006746
-
NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer
Study
EGAS00001006820
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - WGS
Study
EGAS00001006843
-
Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trial
Study
EGAS00001006905
-
Genetic landscape of ENKTCL
Study
EGAS00001006906
-
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer
Study
EGAS00001007291
-
Whole Exome and RNA sequencing of synchronous female bilateral breast cancers
Study
EGAS00001006910
-
Genomic Analysis of a Metastatic Fusion-negative Embryonal Rhabdomyosarcoma
Study
EGAS00001006946
-
Treated and control Patient Derived Xenografts of colorectal cancer (CRC) samples
Study
EGAS00001006973
-
A capture-based next-generation sequencing panel for the molecular characterization of chronic lymphocytic leukemia
Study
EGAS00001006975
-
Whole genome, RNA-seq and single-cell Multiome profile of multiple myeloma
Study
EGAS00001007014
-
RNAseq analysis on primary sites Colorectal Cancer xenografts (PRX) samples
Study
EGAS00001007051
-
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients
Study
EGAS00001007072
-
Point-of-care monitoring of head and neck cancer treatment response and recurrence development using nanopore-based ctDNA consensus sequencing
Study
EGAS00001007090
-
Cell-to-cell variability in Myc dynamics drives transcriptional heterogeneity in cancer cells
Study
EGAS00001007091
-
Human colorectal cancer single-cell RNA sequencing
Study
EGAS50000001348
-
Genomic Landscape of Follicular Lymphoma Across a Wide Spectrum of Clinical Behaviors
Study
EGAS00001007105
-
CRCbiome: Gut metagenome of Norwegian screening participants using FIT sampling
Study
EGAS50000000170
-
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC (Hipo_015)
Study
EGAS00001007143
-
HGSOC organoid sequencing study
Study
EGAS00001007189
-
Integrated genetic analysis of primary CNS lymphoma
Study
EGAS00001007222
-
Early ctDNA molecular response captures therapeutic response in the first stage of CCTG BR.36 ctDNA-directed, multi-center phase II study of molecular response adaptive immunotherapy in non-small cell lung cancer
Study
EGAS00001007298
-
Breast cancer sequencing data
Study
EGAS00001007336